MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Puma Biotechnology Company Profile (NASDAQ:PBYI)

Consensus Ratings for Puma Biotechnology (NASDAQ:PBYI) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $224.33 (136.54% upside)

Analysts' Ratings History for Puma Biotechnology (NASDAQ:PBYI)
Show:
DateFirmActionRatingPrice TargetActions
8/27/2015JPMorgan Chase & Co.Initiated CoverageOverweight$249.71 -> $122.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2015RBC CapitalReiterated RatingOutperform$285.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2015RBC CapitalReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015Citigroup Inc.Boost Price TargetBuy$263.00 -> $266.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2015Bank of AmericaInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2015RBC CapitalInitiated CoverageOutperform$282.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014Stifel NicolausInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2014Citigroup Inc.Boost Price TargetBuy$99.00 -> $292.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2014Leerink SwannBoost Price TargetOutperform$144.00 -> $300.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2014Citigroup Inc.Reiterated RatingBuy$123.00 -> $99.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Citigroup Inc.Initiated CoverageBuy$123.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/24/2013Bank of AmericaBoost Price TargetBuy$118.00 -> $141.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2013Stifel NicolausDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/30/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha